Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Nalena vs PauseRX

Nalena
Graded #97

Higher grade

vs+2.700000000000003
PauseRX
Graded #147

Lower grade

The verdict

Nalena takes it — 71.2/100 to 68.5/100.

Nalena grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Nalena is a women-focused, GLP-1-only telehealth platform offering compounded semaglutide and tirzepatide with medication included — no separate membership or visit fees.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueNalena +8
74
66
Dose & formulationPauseRX +21
64
85
Clinical oversightPauseRX +1
82
83
Labs & monitoringNalena +1
53
52
FulfillmentNalena +28
89
61
Contract termsNalena +20
61
41
Nalena · left barPauseRX · right bar

The numbers

MetricNalenaPauseRX
WeighScore71.2/10068.5/100
GradeCC
Scorecard rank#97#147
Semaglutide$149/mo (starting dose, compounded)$199/mo
Tirzepatide$149/mo (starting dose, compounded)$249/mo (starting dose, compounded)
CoverageAll 50 statesCoverage not published
Brand-name accessCompounded onlyYes
Oral / sublingualInjection onlyInjection only
Nalena

Graded #97 · C

Strengths

  • Compounded GLP-1 from $149/mo with medication included — near the floor of the compounded market
  • Transparent fee model: no hidden fees, no membership, cancel anytime
  • Money-back guarantee — uncommon among compounded telehealths
  • Clinical provider disclosed: Beluga Health, P.A. in Houston, TX
  • Women-focused positioning

Where it loses points

  • Per-dose pricing not published — only the 'starting at $149' entry price
  • No LegitScript, HIPAA, or NABP badges on public pages
  • Compounding pharmacy partners not named (only 'multiple USA certified pharmacies')
  • Houston address looks like a virtual office rather than a clinical facility
  • No brand-name GLP-1s (Wegovy, Zepbound, Ozempic, Mounjaro) — compounded only
PauseRX

Graded #147 · C

Strengths

  • Names its 503A pharmacy partner (Strive Pharmacy, Gilbert AZ) — buyers can independently verify its licensure
  • Names its physician network (Beluga Health) — you can research the clinical platform handling your prescriptions
  • Publishes the FDA compounded-medication disclaimer
  • Corporate legal entity disclosed (PauseRX, Inc.) — uncommon for direct-to-consumer GLP-1 platforms
  • Flat $199 'all doses' compounded semaglutide pricing — no per-tier escalation

Where it loses points

  • States served not listed — site claims nationwide, but you must contact support to confirm availability
  • Restrictive cancellation policy — orders can't be changed or canceled once submitted, and medications can't be returned
  • No named medical director (Beluga Health is the network, not a named MD)
  • LegitScript certification number not shown — badge only, so no direct lookup
  • Insurance not accepted — cash-pay only; HSA/FSA eligibility not confirmed

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard